Cohance Lifesciences Ltd. Company History and Annual Growth Details

The Company was incorporated as a public limited company under the Companies Act, 2013, in Hyderabad, Telangana,

India, pursuant to a certificate of incorporation dated November 6, 2018 issued by the Registrar of Companies,

Telangana, at Hyderabad.

2020

-Suven Pharmaceuticals Ltd. has issued Bonus Shares in the Ratio of 1:1.

2021

-CSIR-IICT and SUVEN Pharmaceuticals Ltd., joined hands for the process technology
transfer and manufacture of anti COVID drugs Molnupiravir and 2-DG.

2022

-Advent to acquire significant stake in Suven Pharmaceuticals from Jasti family.
-Suven Pharmaceuticals approves acquisition of Casper Pharma.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article